McKesson stock rallies and ends six-day losing streak

7 articles · Updated · MarketWatch · May 7

Shares rose 1.49% to $754.76 on Thursday as the S&P 500 fell 0.38% and the Dow dropped 0.63%.
McKesson outperformed Amazon, which fell 1.39%, while UnitedHealth gained 0.67% and CVS added 0.58%.
Trading volume reached 1.9 million, above its 50-day average, though the stock remains 24.45% below its $999 52-week high hit on 3 March.

With a revenue miss despite its rally, can McKesson's new CFO close the 24% gap to its 52-week high?

With regulators circling its top rival, could McKesson's market dominance place it next in the government's antitrust crosshairs?

As a $200B 'patent cliff' looms, is McKesson's strategy ready to capture the massive market shift to generic drugs?